معرفی
Guojun Chen is an Assistant Professor at the Department of Biomedical Engineering and a member of the Rosalind & Morris Goodman Cancer Institute (GCI) at McGill University. His research focuses on engineering intelligent biomaterials for precision medicine, with emphasis on non-viral genome editing, cold atmospheric plasma (CAP) therapy, and biomaterials-mediated immunotherapy. The lab operates in a multidisciplinary environment, integrating principles from materials science, chemistry, biology, and health sciences.
- Education: Ph.D. from University of Wisconsin-Madison (2017), Postdoc at UCLA (2020)
Research Themes:
- Genome Editing Delivery: Designing non-viral vectors for efficient CRISPR/Cas9 delivery in vivo.
- CAP-mediated Immunotherapy: Developing portable cold plasma devices to synergize with immune checkpoint blockade and study CAP’s immunological mechanisms.
- Biomaterials-based Immunotherapy: Reprogramming tumor microenvironments using bioresponsive materials to enhance immune responses.
Publication Trends: Recent work spans responsive nanomaterials, genomic editing systems, and plasma oncology, with a focus on cancer immunotherapy, diabetes diagnostics, and bioinspired medical devices.
Scientific Awards:
- Canada Research Chair (2024, 2025)
- McGill's President's Prize for Emerging Researchers (2025)
- FRQS Chercheurs-boursiers (2022)
- Chinese Association for Biomaterials Young Investigator Award (2022)
- NSERC Discovery Grant (2021)
Advising & Grants: Supervises 14 current graduate and undergraduate students. Secured $5M+ in funding from CIHR, NSERC, CCS, and CFI, including multi-institutional collaborations with Dr. Morag Park, Dr. Réjean Lapointe, and Dr. Ian Watson.
